Investigation of the Acute Effects of Traditional and Functional IMT on Muscle Oxygenation in COPD
1 other identifier
interventional
24
1 country
1
Brief Summary
This study aims to compare the effects of functional and conventional inspiratory muscle training (IMT) on post-exercise muscle deoxygenation in individuals with Chronic Obstructive Pulmonary Disease (COPD). Participants will complete both training modalities on separate days. A 2-minute walk test (2MWT) will be performed baseline, and after each session. Muscle oxygenation (SmO₂) will be assessed using near-infrared spectroscopy . Dyspnea and fatigue will be evaluated with the Modified Borg Scale, and heart rate and oxygen saturation (SpO₂) will be measured by pulse oximetry. Measurements will be recorded before, after training and at the end of the walking test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2025
CompletedFirst Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2026
CompletedApril 9, 2026
November 1, 2025
2 months
November 17, 2025
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle oxygenation levels (SmO₂)
Muscle oxygenation (SmO₂) will be assessed using near-infrared spectroscopy .
1. day - baseline measurement-before and after 2MWT , 1. day- before and after IMT and after 2MWT 2. day- before and after FIMT and after 2MWT
Secondary Outcomes (5)
Fatigue
1. day - baseline measurement-before and after 2MWT , 1. day- before and after IMT and after 2MWT 2. day- before and after FIMT and after 2MWT
Dyspnea
1. day - baseline measurement-before and after 2MWT , 1. day- before and after IMT and after 2MWT 2. day- before and after FIMT and after 2MWT
Heart rate
1. day - baseline measurement-before and after 2MWT , 1. day- before and after IMT and after 2MWT 2. day- before and after FIMT and after 2MWT
Saturation (SPO2)
1. day - baseline measurement-before and after 2MWT , 1. day- before and after IMT and after 2MWT 2. day- before and after FIMT and after 2MWT
hemoglobin
1. day - baseline measurement-before and after 2MWT , 1. day- before and after IMT and after 2MWT 2. day- before and after FIMT and after 2MWT
Study Arms (1)
Chronic Obstructive Pulmonary Disease
EXPERIMENTALInterventions
Functional inspiratory muscle training (IMT) is defined as inspiratory muscle training performed while maintaining core stabilization and postural control. Functional IMT consists of a warm-up period, core exercises, dynamic trunk activation combined with upper extremity movements, postural control exercises, and a cool-down period. The participant performs these exercises simultaneously with inspiratory muscle training.
Traditional inspiratory muscle training is a form of training performed using a resistive breathing device that provides resistance to the muscles involved in inspiration. Inspiratory muscle training will be performed using a portable pressure-threshold device (POWERbreathe Classic IMT - Light Resistance). IMT will be administered in a seated position with upper extremities supported and the upper chest/shoulders relaxed. The training procedure will be explained to each participant and performed for 15 minutes at 40% of the maximal inspiratory pressure (MIP).
Eligibility Criteria
You may qualify if:
- Being 18 years of age or older,
- Having a diagnosis of COPD,
- Being in stage II-III according to the GOLD classification,
- Being able to mobilize independently.
You may not qualify if:
- Having a recent exacerbation or complication requiring hospitalization,
- Having had a respiratory tract infection within the past month,
- Having any disease or medical condition that prevents participation in exercise, -Having cognitive impairment (a score of \<24 on the Mini-Mental Test).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulhane Faculty of Physiotherapy and Rehabilitation
Ankara, Keçiören, 06018, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
December 5, 2025
Study Start
November 11, 2025
Primary Completion
January 1, 2026
Study Completion
February 15, 2026
Last Updated
April 9, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share